Psychotropic Medication and Psychosocial Service Use among Transition Age Youth with Autism Spectrum Disorder
Saved in:
| Title: | Psychotropic Medication and Psychosocial Service Use among Transition Age Youth with Autism Spectrum Disorder |
|---|---|
| Language: | English |
| Authors: | Emma R. Plourde, Mir M. Ali, Kristina D. West |
| Source: | American Journal on Intellectual and Developmental Disabilities. 2024 129(1):1-9. |
| Availability: | American Association on Intellectual and Developmental Disabilities. P.O. Box 1897, Lawrence, KS 66044-1897. Tel: 785-843-1235; Fax: 785-843-1274; e-mail: AJMR@allenpress.com; Web site: https://meridian.allenpress.com/aaidd |
| Peer Reviewed: | Y |
| Page Count: | 9 |
| Publication Date: | 2024 |
| Document Type: | Journal Articles Reports - Research |
| Descriptors: | Autism Spectrum Disorders, Mental Health, Youth, Adolescents, Young Adults, Psychological Needs, Individual Development, Mental Health Programs, Drug Therapy, Transitional Programs |
| DOI: | 10.1352/1944-7558-129.1.1 |
| ISSN: | 1944-7515 1944-7558 |
| Abstract: | People with autism spectrum disorder (ASD) experience high rates of psychotropic medication utilization and barriers to psychosocial services, yet limited literature explores use of these services and the association between a mental health condition (MH) and use. Using national multipayer claims data, this study estimates a multinomial logistic regression model to discern psychotropic medication and psychosocial service use among transition age youth (TAY) with ASD (12-26 years; N = 52,083) compared to a matched cohort of those without ASD (12-26 years; N = 52,083). Approximately one-third of TAY with ASD and no MH condition receive only psychotropic medication and the likelihood of using both psychosocial services and medication is higher only when TAY with ASD have a co-occurring MH condition. |
| Abstractor: | As Provided |
| Entry Date: | 2024 |
| Accession Number: | EJ1412479 |
| Database: | ERIC |
| Abstract: | People with autism spectrum disorder (ASD) experience high rates of psychotropic medication utilization and barriers to psychosocial services, yet limited literature explores use of these services and the association between a mental health condition (MH) and use. Using national multipayer claims data, this study estimates a multinomial logistic regression model to discern psychotropic medication and psychosocial service use among transition age youth (TAY) with ASD (12-26 years; N = 52,083) compared to a matched cohort of those without ASD (12-26 years; N = 52,083). Approximately one-third of TAY with ASD and no MH condition receive only psychotropic medication and the likelihood of using both psychosocial services and medication is higher only when TAY with ASD have a co-occurring MH condition. |
|---|---|
| ISSN: | 1944-7515 1944-7558 |
| DOI: | 10.1352/1944-7558-129.1.1 |
